STOCK TITAN

Cycurion, Inc. Announces Scheduled Nasdaq Listing Hearing and Reaffirms Commitment to Maintaining Nasdaq Listing

(Neutral)
Tags

Cycurion (NASDAQ: CYCU) has requested and obtained a scheduled hearing before the Nasdaq Hearings Panel in August 2026 to appeal a July 10, 2026 delisting determination tied to the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(1). The hearing request stays any suspension or delisting action, so CYCU shares are expected to continue trading on The Nasdaq Capital Market at least through the hearing and any extension period. According to Cycurion, it plans to present a compliance plan at the hearing and continues to advance its core business operations.

Loading...
Loading translation...

Positive

  • Nasdaq hearing secured for August 2026, delaying any delisting action
  • CYCU shares expected to keep trading on Nasdaq at least through hearing period
  • Company will present a formal plan to regain and maintain Nasdaq compliance
  • Cycurion reports it is continuing to advance core business operations

Negative

  • Nasdaq delisting determination received July 10, 2026 for minimum bid price non-compliance
  • Ongoing risk to Nasdaq listing status under Listing Rule 5550(a)(1)

Market reaction after Nasdaq listing hearing: CYCU +8.09% in the Jul 22 session

+8.09% 21.4x vol
63 alerts
+8.09% Session close to close
+38.5% Peak Tracked
-10.9% Trough Tracked
$3.56M Market Cap
21.4x Rel. Volume

In the Jul 22 session, CYCU gained 8.09%, reflecting a notable positive market reaction. Argus tracked a peak move of +38.5% during that session. Argus tracked a trough of -10.9% from its starting point during tracking. Our momentum scanner triggered 63 alerts that day, indicating high trading interest and price volatility. Trading volume was exceptionally heavy at 21.4x the daily average, suggesting very strong buying interest.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved +8.1% in the session following this news. 10.63% was CYCU's 24-hour reaction to the ...
Analysis

The stock moved +8.1% in the session following this news. 10.63% was CYCU's 24-hour reaction to the July 14 expansion update, while this notice addressed Nasdaq listing continuity. JZ also rose 5.53% at publication; the unresolved compliance process remained a sourced risk.

Key Figures

Delisting determination date: July 10, 2026 Hearing timing: August 2026
2 metrics
Delisting determination date July 10, 2026 Nasdaq minimum bid price requirement
Hearing timing August 2026 Nasdaq Hearings Panel appeal

Historical Context

5 past events · Latest: Jul 16 (Negative)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jul 16 Nasdaq delisting notice Negative -32.7% Delisting determination followed 31 consecutive business days below Nasdaq's minimum bid price.
Jul 14 Expansion strategy update Positive +10.6% Management outlined acquisitions, new revenue streams, and an annualized revenue target above $30 million.
Jul 08 Reverse split decision Positive -5.6% Management declined a planned 7-for-1 reverse stock split while highlighting business fundamentals.
Jun 29 Asset acquisition agreement Positive -7.5% Cycurion agreed to acquire a video-solutions segment with approximately $5.1 million annual revenue.
Jun 15 Shareholder response Positive +12.3% Cycurion addressed alleged trading issues while describing efforts to strengthen core business operations.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent company news produced both aligned and divergent price reactions, including sharp declines after Nasdaq and acquisition announcements.

Key Terms

nasdaq hearings panel, delisting determination, minimum bid price requirement
3 terms
nasdaq hearings panel regulatory
"requested a hearing before the Nasdaq Hearings Panel"
A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.
delisting determination regulatory
"appeal the delisting determination the Company received on July 10, 2026"
A delisting determination is a formal decision by a stock exchange or regulator to remove a company’s shares from the official trading list, usually after the company fails to meet rules such as filing reports, maintaining a minimum share price, or staying solvent. It matters to investors because removal reduces or eliminates easy ways to buy or sell the shares, can sharply lower their value, and forces holders to trade in smaller, riskier markets — like having to sell a car at a neighborhood garage sale instead of a busy dealership.
minimum bid price requirement regulatory
"relating to the minimum bid price requirement under Nasdaq Listing Rule"
A minimum bid price requirement is a rule that a stock must trade above a set price for a specified period to stay listed on an exchange. It matters to investors because falling below that threshold can trigger warnings or removal from the exchange, which can cut liquidity, reduce visibility, and often lead to sharper declines in share value—think of it like a venue’s minimum dress code that, if not met, can bar a performer from the stage.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MCLEAN, Va., July 22, 2026 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a leading AI-driven, tech-enabled cybersecurity solutions provider, today announced that, as planned and previously disclosed, it requested a hearing before the Nasdaq Hearings Panel (the “Panel”) to appeal the delisting determination the Company received on July 10, 2026, relating to the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(1). The hearing has been scheduled and is expected to take place in August 2026.

The Company’s hearing request has stayed any suspension or delisting action pending the hearing and the expiration of any extension period that may be granted by the Panel following the hearing. Accordingly, the Company’s common stock is expected to continue to trade on The Nasdaq Capital Market under the symbol “CYCU” at least through that period.

At the hearing, the Company intends to present its plan to regain and maintain compliance with the applicable Nasdaq listing standards.

Cycurion continues to advance its core business operations while working through the Nasdaq hearings process.

About Cycurion, Inc.
Based in McLean, Virginia, Cycurion (NASDAQ: CYCU) is a forward-thinking provider of IT cybersecurity solutions and AI, committed to delivering secure, reliable, and innovative services to clients worldwide. Specializing in cybersecurity, program management, and business continuity, Cycurion harnesses its AI-enhanced ARx platform and expert team to empower clients and safeguard their operations. Along with its subsidiaries, Axxum Technologies LLC, Cloudburst Security LLC, and Cycurion Innovation, Inc., Cycurion serves government, healthcare, and corporate clients committed to securing the digital future. More info: www.cycurion.com.

Forward-Looking Statements
This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the operations and prospective growth of Cycurion’s business.

Certain statements in this press release that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Such statements include, but are not limited to, the Company's appeal of Nasdaq's delisting determination; the outcome of the Company’s hearing before the Nasdaq Hearings Panel; the Company’s ability to regain and maintain compliance with Nasdaq’s continued listing requirements; the acceleration of the Company’s inorganic growth strategy through potential acquisitions and strategic transactions; the continued execution of the Company’s contracted backlog; and other statements that are not historical facts, including statements which may be accompanied by words such as “continue,” “will,” “may,” “could,” “should,” “expect,” “expected,” “plans,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” and similar expressions intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Cycurion and are difficult to predict. Examples of such risks and uncertainties include, but are not limited to, the outcomes of the Company’s investigations, any potential legal proceedings, or the future performance of the Company’s stock. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K filed by Cycurion with the U.S. Securities and Exchange Commission. Cycurion anticipates that subsequent events and developments may cause its plans, intentions, and expectations to change. Cycurion assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as expressly required by law. Forward-looking statements speak only as of the date they are made and should not be relied upon as representing Cycurion’s plans and expectations as of any subsequent date.

Cycurion Investor Relations:
(888) 341-6680
investors@cycurion.com

Cycurion Media Relations:
(888) 341-6680
media@cycurion.com


FAQ

Why did Cycurion (NASDAQ: CYCU) receive a Nasdaq delisting determination on July 10, 2026?

Cycurion received a Nasdaq delisting determination for not meeting the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(1). According to Cycurion, this determination specifically relates to the bid price criterion for continued listing on The Nasdaq Capital Market.

What is the date of Cycurion's Nasdaq Hearings Panel meeting about the CYCU listing?

Cycurion’s hearing before the Nasdaq Hearings Panel is scheduled to take place in August 2026. According to Cycurion, this hearing will address its appeal of the July 10, 2026 delisting determination and its plan to regain listing compliance.

Will Cycurion (CYCU) continue trading on Nasdaq during the listing appeal process?

Cycurion’s common stock is expected to continue trading on The Nasdaq Capital Market under symbol CYCU at least through the hearing and any extension period. According to Cycurion, the hearing request automatically stays suspension or delisting actions during this timeframe.

What rule is Cycurion accused of violating in the July 2026 Nasdaq delisting notice?

The July 10, 2026 Nasdaq delisting determination concerns Cycurion’s minimum bid price under Nasdaq Listing Rule 5550(a)(1). According to Cycurion, the issue is limited to this bid price listing standard, not other Nasdaq listing requirements.

How does Cycurion plan to regain Nasdaq compliance for CYCU shares?

Cycurion intends to present its plan to regain and maintain compliance with applicable Nasdaq listing standards at the August 2026 hearing. According to Cycurion, it remains focused on advancing its core business while pursuing this compliance strategy.

What does the Nasdaq listing hearing mean for Cycurion (CYCU) shareholders?

The scheduled Nasdaq hearing means CYCU shares are expected to keep trading during the appeal and any extension period. According to Cycurion, the hearing allows it to present a detailed compliance plan before any final delisting decision is made.